Steven Cohen's TARS Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 37,628 shares of Tarsus Pharmaceuticals, Inc. (TARS) worth $3.08 M, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Steven Cohen has maintained this position in TARS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 37,628 shares. Largest reduction occurred in Q4 2023, reducing 79,725 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Tarsus Pharmaceuticals (TARS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tarsus Pharmaceuticals (TARS) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +37,628 | New Buy | 37,628 | $81.88 |
| Q1 2024 | -19,575 | Sold Out | 0 | $0.00 |
| Q4 2023 | -79,725 | Reduce 80.29% | 19,575 | $20.25 |
| Q3 2023 | +99,300 | New Buy | 99,300 | $17.77 |
Steven Cohen's Tarsus Pharmaceuticals Investment FAQs
Steven Cohen first purchased Tarsus Pharmaceuticals, Inc. (TARS) in Q3 2023, acquiring 99,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Tarsus Pharmaceuticals, Inc. (TARS) for 4 quarters since Q3 2023.
Steven Cohen's largest addition to Tarsus Pharmaceuticals, Inc. (TARS) was in Q3 2023, adding 99,300 shares worth $1.76 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 37,628 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $3.08 M.
As of the Q4 2025 filing, Tarsus Pharmaceuticals, Inc. (TARS) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Tarsus Pharmaceuticals, Inc. (TARS) was 99,300 shares, as reported at the end of Q3 2023.